Compare BWFG & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWFG | MASS |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 525.2M | 449.7M |
| IPO Year | 2014 | 2020 |
| Metric | BWFG | MASS |
|---|---|---|
| Price | $65.27 | $12.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $69.50 | $13.38 |
| AVG Volume (30 Days) | 56.6K | ★ 289.1K |
| Earning Date | 10-22-2026 | 11-09-2026 |
| Dividend Yield | ★ 1.24% | N/A |
| EPS Growth | ★ 261.79 | 125.47 |
| EPS | ★ 2.95 | N/A |
| Revenue | $2,826,000.00 | ★ $56,197,000.00 |
| Revenue This Year | $20.01 | $22.97 |
| Revenue Next Year | $6.51 | $19.41 |
| P/E Ratio | $22.00 | ★ N/A |
| Revenue Growth | ★ 43.96 | N/A |
| 52 Week Low | $40.45 | $5.03 |
| 52 Week High | $69.59 | $11.89 |
| Indicator | BWFG | MASS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 68.40 |
| Support Level | N/A | $5.86 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.56 |
| MACD | 0.00 | 0.15 |
| Stochastic Oscillator | 0.00 | 89.81 |
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.